Download PDF
1
/
Pages
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Integrating different perspectives to define a concept of comprehensive remission in rheumatoid arthritis: The SUMAR project
Alejandro Balsa; José Luis Andreu; Juan Carlos Hermosa-Hernán; Josefa León-Navarro; Jordi Nicolas Pico; José Javier Pérez Venegas; Susana Romero-Yuste; Raimon Sanmarti; Antonio Ignacio Torralba Gómez-Portillo; Juan Carlos Valenzuela-Gámez; Jordi Cohen;
Reumatol Clin. 2025;21:
Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price
Mariángeles González Fernández; Elena Villamañán; Inmaculada Jiménez-Nácher; Francisco Moreno; Chamaida Plasencia; Francisco Gayá; Alicia Herrero; Alejandro Balsa;
Reumatol Clin. 2021;17:335-42
Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis
José Rosas; María Martín-López; Teresa Otón; Alejandro Balsa; Jaime Calvo-Alén; Raimon Sanmartí; Jesús Tornero; Loreto Carmona;
Reumatol Clin. 2020;16P2:378-85